What AFPs Are, How They Evolved, and Why They Matter Now
April 23, 2026
Part 1 of Our AFP Intelligence Series: The Hidden Threat to Specialty Brand Revenue & Patient Care Alternate Funding Programs have evolved into a powerful
Part 1 of Our AFP Intelligence Series: The Hidden Threat to Specialty Brand Revenue & Patient Care Alternate Funding Programs have evolved into a powerful
Part 2 of Our AFP Intelligence Series: The Hidden Threat to Specialty Brand Revenue & Patient Care AFPs operate as coordinated workflows—not isolated programs—redirecting patients,
Part 3 of Our AFP Intelligence Series: The Hidden Threat to Specialty Brand Revenue & Patient Care AFPs don’t simply shift costs—they can also introduce
The Emerging Prerequisite to Drug Affordability: Digital Patient Engagement Drug affordability is one of the biggest barriers to therapy initiation and adherence, but costalone isn’t
Part 2 of Our Series: Reimagining Patient Services with Conversational AI What does “infinite engagement” actually look like in practice? Conversational AI makes itpossible to
Part 1 of Our Series: Reimagining Patient Services with Conversational AI Conversational AI enables pharmaceutical companies to streamline high-volume patientservices, reduce friction at critical access
Part 4 of Our AFP Intelligence Series: The Hidden Threat to Specialty Brand Revenue & Patient Care AFPs are difficult to detect by design. Building